The Measles & Rubella Initiative is a global partnership to lead and coordinate efforts to achieve a world without measles and rubella.


The Measles & Rubella Initiative (M&RI) is led by the American Red Cross, the United Nations Foundation, the U.S. Centers for Disease Control and Prevention, UNICEF and the World Health Organization.

The M&RI aims to reach the measles and rubella elimination goals of the Global Vaccine Action Plan by supporting countries to raise coverage of measles, rubella and other vaccines; fund, plan, implement and monitor quality supplementary campaigns; investigate outbreaks and provide technical and financial support for effective outbreak response, propose and participate in solutions to strengthen immunization delivery; and support a global laboratory network for measles and rubella.

The Initiative is focused on supporting the goal of reducing global measles mortality by 95 percent by 2015; and eliminating measles and rubella in at least five of the six World Health Organization Regions by 2020.

Since 2001, the Initiative has supported 80 countries to deliver more than 2 billion doses of measles vaccine, helped to raise measles vaccination coverage to 85% globally, and reduced measles deaths by 79%. These efforts have contributed significantly to reducing child mortality as per Millennium Development Goal 4. To date, the partnership has invested more than US $1.2 billion in measles and rubella control activities.

In 2014, the Measles & Rubella Initiative supported 29 countries to implement measles campaigns that reached more than 221 million children with bundled vaccines, operational costs or technical assistance.

Key supporters of the Measles & Rubella Initiative include countries and governments affected by measles, rubella and congenital rubella syndrome;

The Measles & Rubella Initiative is also grateful to its many individual private donors and supporters. Together we move faster.